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Auto-contouring performances for post-op prostate cancer 
were similar to those of intact prostate cancer. Compared to 
similar other study without rectal balloon, rectal DSC was 
significantly improved with the rectal balloon. 
Bladder and rectum of post-op endometrium cancer showed 
improvement as increasing the number of atlas match and 
reached to modest agreement when the number of atlas 
match was 5. On the contrast, DSCs of FHs were almost 
independent on the number of atlas match. 
Conclusions: For prostate and endometrium cancer, ABAS 
could be a useful tool for FHs and rectum with ballooning. 
CTV, bladder, rectum without ballooning, should be reviewed 
and may require editing. The placement of a rectal balloon 
and a strict protocol for bladder voiding could help the auto-
contouring process for the prostate patient. Increasing the 
number of atlas match for bladder and rectum improves 
accuracy of ABAS, but auto-contouring time increases.  
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Purpose/Objective: Stereotactic body radiotherapy (SBRT) is 
mainly used on small and well defined targets, thus the 
clinical experience on treating extended tumor volumes is 
limited. The feasibility of this approach is still controversial 
on large volumes, especially for moving targets. The lack of 
accuracy in target positioning forces the expansion of CTV 
margins. Target size represents the highest limitation for 
SBRT, due to the increased complexity necessary to achieve 
dose constrains for organs at risk (Grimm et al 2011). Several 
studies show that for many primary tumors 18F-FDG PET-CT 
has a high sensitivity. When clinically adequate, the 
opportunity to reduce the target volume on the basis of 
metabolic activity should be considered. The improvement in 
deformable imaging registration (DIR) allows to combine CT 
simulation scans with CT-PET, offering a new strategy in 
tumor metabolic active area identification and target 
delineation (Cho et al 2013, Fortin et al 2014). The purpose 
of this study was to evaluate, when extended targets are 
considered, the reliability of using PET deformed on planning 
CT and the chance to reduce the target size based on PET 
data. 
Materials and Methods: Six metastatic patients characterized 
by large target volumes (100-15400 ml) were selected to 
undergo SBRT (10 Gy in 3 fx). The patients (2 ovaric, 3 lung 
and 1 rectum as primary tumor) had metastasis respectively 
located in abdomen, liver, paracardiac, neck, perirectal and 
lung regions. PET-CT images and planning CT were separately 
collected. Both rigid registration (RIR) and DIR were 
performed, fusing diagnostic CT (PET related) and planning 
CT. PET voxels were deformed on the basis of the CT-CT 
fusion and registered with the planning CT. Volumes of 40% 
for SUVmax were collected on RIR and DIR images, by the use 
of threshold segmentation within a VOI of equal size. Dice 
similarity coefficient (DSC) was used for conformity 
evaluation between RIR and DIR (Fortin et al 2014). DSC 
higher than 0.7 was considered as acceptable level of 
conformity. 
Results: DSC resulted higher than 0.7 only for two patients 
(DSC=0.80±0.05) and lower for the remaining four patients 
(DSC=0.31±0.16). Low DCS values were related to a 
substantial difference between the diagnostic and planning 
CT, due a different use of immobilization devices, positioning 
(arms up and down, neck position) or target motion, mainly 
respiratory. 
Conclusions: Since voxel intensity is not preserved in PET-CT 
deformed images, a high DSC is highly desirable. DSC can be 
interpreted, more then conformity, as an index of position 
reproducibility and used as an indication of registration 
reliability. Our results underlined the importance of adopting 
the same immobilization device and body positioning in both 
treatment planning and PET-CT. In this context, we suggest 
the adoption, as cut off, of DSC value higher than 0.7, when 
referring to PET-CT images. 
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Purpose/Objective: Radiotherapy for patients with 
nasopharyngeal carcinoma (NPC) may result in high radiation 
dose to the brachial plexus (BP) resulting in radiation-induced 
brachial plexopathy (RIBP). In order to control and analyze 
the radiation dose delivered to the BP, accurate delineation 
and application of dose constraints during planning 
optimization are crucial. The aim of this study was to 
evaluate the radiation dose to BP by following the Radiation 
Therapy Oncology Group- endorsed contouring atlas (RTOG-
eCA) and to analyze the dosimetric consequences on applying 
dose constraints to BP in tomotherapy planning optimization 
of NPC. 
Materials and Methods: 15 patients with NPC regardless of 
the staging were retrospectively selected. Both MR and CT 
images of the neck region for image registration should be 
available. Apart from original treatment plan (Plan A) in 
which no dose constraint was applied to BP, two new 
tomotherapy plans (Plan B & C) were computed using the 
same set of planning CT images and the same treatment 
parameters. Plan B consisted of BP contours based on RTOG-
eCA while Plan C consisted of BP contours based on MR 
images registered with the planning CT images. Additional 
dose constraints to BP were added to both Plan B & C aiming 
to keep the maximum dose < 60Gy. The end-point was that 
both Plan B & C achieved the same dose outcome as Plan A, 
and the Dmax of the non-target BP was kept < 60Gy. The new 
BP contours based on both CT and MR were also added to 
Plan A to evaluate whether the original BP dose exceeded the 
RTOG recommended dose limit using the MIM software. For 
each patient, dose-volume histograms of the BP for both Plan 
A, B & C would be generated for dose comparison. BP 
volumes, Dmax, Dmean, D5%, D10% and D15% were compared. 
Contours among Plan B & C on both axial CT slices and 
corresponding beam’s eye views were also compared visually. 
